Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early fluorodeoxyglucose positron emission tomography-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer

Head & Neck ◽  
2015 ◽  
Vol 38 (3) ◽  
pp. 347-354 ◽  
Author(s):  
Yassine Lalami ◽  
Camillo Garcia ◽  
Patrick Flamen ◽  
Lieveke Ameye ◽  
Marianne Paesmans ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document